According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

Changing market conditions and consumer tastes and preferences have weighed on these businesses. Investors can learn a lot ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

Achieve Life Sciences has signed up Omnicom to support the launch of nicotine dependence treatment cytisinicline, positioning ...

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

The most powerful EU official faces a challenge to her authority, if not her hold on office, thanks to a censure motion. Center-left EU lawmakers seized the moment to slam cooperation with the far ...

If RFK has his way, even if you still have coverage, you may not be able to afford the shots that your doctor wants to give.

A political firestorm has erupted in Brussels as French MEPs accuse European Commission President Ursula von der Leyen of secretly negotiating a €35 billion vaccine deal with Pfizer—via SMS. With no ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

The president of the European Union’s executive branch, Ursula von der Leyen, faces a no-confidence vote this week linked in ...